Jasper Therapeutics, Inc. - Class A Common Stock (NQ:JSPR)

0.8141 -0.0709 (-8.01%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jasper Therapeutics, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Nasdaq Falls Over 100 Points; Capgemini To Acquire WNS ↗

July 07, 2025

Via Benzinga

What's going on in today's pre-market session ↗

July 07, 2025

Wondering what's happening in Monday's pre-market session? Find an overview in this article.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 07, 2025

Via Benzinga

Russell 2000 Index Forecast As The Crash Continues: Buy The Dip? ↗

April 22, 2025

The Russell 2000 Index has plunged and formed a death cross this year as American stocks sink amid rising worries about Donald Trump’s policies.

Via Talk Markets

Topics Government Stocks / Equities

JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q4 2023 ↗

March 06, 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Via InvestorPlace

Jasper Therapeutics: Q3 Earnings Insights ↗

November 09, 2023

Via Benzinga

Where Jasper Therapeutics Stands With Analysts ↗

May 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 08, 2025

Via Benzinga

Crude Oil Down 1%; US Weekly Jobless Claims Decline ↗

January 08, 2025

Via Benzinga

Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors ↗

January 08, 2025

Jasper Therapeutics reports strong briquilimab efficacy in CSU with UAS7 reductions, dose-dependent responses, and Phase 2b plans by late 2025.

Via Benzinga

US Stocks Down; Acuity Brands Posts Weak Revenue ↗

January 08, 2025

Via Benzinga

Futures Slump As Yields, Dollar Soar ↗

January 08, 2025

In premarket trading Quantum stocks tumbled after Nvidia CEO Jensen Huang said that “very useful” quantum computers are likely decades away.

Via Talk Markets

Topics Commodities Stocks / Equities

Jasper Therapeutics: Q1 Earnings Insights ↗

May 12, 2023

Via Benzinga

Why Is Chronic Disease-Focused Jasper Therapeutics Stock Trading Higher On Monday? ↗

October 14, 2024

Jasper Therapeutics' SPOTLIGHT study reports 93% clinical response in cold urticaria and symptomatic dermographism. The 120mg dose showed 83% complete response and no severe adverse events. Full data...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 09, 2024

Via Benzinga

JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q2 2024 ↗

August 13, 2024

JSPR stock results show that Jasper Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q1 2024 ↗

May 14, 2024

JSPR stock results show that Jasper Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 20, 2024

Via Benzinga

Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday ↗

May 06, 2024

Via Benzinga

Over $15M Bet On Aon? Check Out These 3 Stocks Insiders Are Buying ↗

February 12, 2024

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.

Via Benzinga

Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 06, 2024

Shares of FMC Corporation (NYSE: FMC) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 17, 2024

Via Benzinga

Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 18, 2023

From Jasper Therapeutics, Inc.

Via GlobeNewswire

Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

November 09, 2023

From Jasper Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 11, 2023

Via Benzinga

Jasper Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update

August 11, 2023

From Jasper Therapeutics, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023 ↗

August 11, 2023

Via Benzinga

Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus

July 13, 2023

Regulatory filings show Gilead Sciences' purchase of shares in AlloVir and Arcus. Strategic investments in the biotech sector are fairly common to boost growth.

Via MarketBeat

Topics Retirement

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.